Additionally, when overexpression of the trans-dominant negative, catalytically inactive mutant K296R was used to inhibit PKR in neuroblastoma cells, it protected the cells from undergoing apoptosis (Vaughn et al., 2014). This evidence concerns the gene EIF2AK2 and neuroblastoma.